company

ZANZUEL & KLINIKK NOVA AS

4611 KRISTIANSAND S

Return on Equity
3,54 %
Current Ratio
1,45
Debt-to-Equity Ratio
−2,07
Key figures (NOK)2022
Revenue4 141 000
Net Income−30 000
Total Assets1 784 000
Total Equity−847 000
Income (NOK)2022
Revenue4 141 000
Expenditure1 948 000
Operating Profit16 000
Financial Income2 000
Financial Costs56 000
Financial Balance−54 000
Earnings Before Tax−38 000
Tax−8 000
Net Income−30 000
Balance (NOK)2022
Total Fixed Assets518 000
Total Current Assets1 266 000
Total Assets1 784 000
Total Retained Equity−1 447 000
Total Equity−847 000
Total Long-Term Debt1 755 000
Total Current Debt875 000
Total Equity and Debt1 784 000
Cash flow (NOK)2022
Sales Income3 995 000
Other Income145 000
Revenue4 141 000
Cost of Goods Sold0
Salary Costs902 000
Depreciation57 000
Impairment0
Expenditure1 948 000
Operating Profit16 000
Financial Income2 000
Financial Costs56 000
Financial Balance−54 000
Dividends0
Net Income−30 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets408 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures110 000
Total Tangible Assets110 000
Total Fiancial Fixed Assets0
Total Fixed Assets518 000
Stock1 061 000
Total Investments1 000
Cash, Bank159 000
Total Current Assets1 266 000
Total Assets1 784 000
Total Equity−847 000
Short-Term Group Debt0
Total Long-Term Debt1 755 000
Creditors118 000
Unpaid Taxes143 000
Dividends0
Other Current Debt350 000
Total Current Debt875 000
Total Equity and Debt1 784 000
Financial indicators2022
Return on Equity3,54 %
Debt-to-Equity Ratio−2,07
Operating Profit Margin0,39 %
Current Ratio1,45
Quick Ratio−6,81
Equity Ratio−0,47
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English